"At GenesisCare (formerly 21st Century Oncology), we offer multidisciplinary personalized cancer treatments based on individual patient needs. From the latest techniques and cutting-edge technologies to our highly skilled team of physicians, we provide world-class cancer care close to home."

During the past decade, GenesisCare USA - Henderson conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 18 clinical trials were completed, i.e. on average, 26.9% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 16 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "GenesisCare USA - Henderson" #1 sponsor was "National Cancer Institute (NCI)" with 64 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "Children's Oncology Group" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "GenesisCare USA - Henderson" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Brain Science Foundation" with 1 trials as a collaborator and "Exelisis" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "GenesisCare USA - Henderson" are "Stage IV Cutaneous Melanoma AJCC v6 and v7" (5 trials), "Recurrent Lung Non-Small Cell Carcinoma" (4 trials), "Stage III Cutaneous Melanoma AJCC v7" (4 trials), "Unresectable Melanoma" (4 trials) and "Anal Basaloid Carcinoma" (3 trials). Many other conditions were trialed in "GenesisCare USA - Henderson" in a lesser frequency.

Most popular intervention types in "GenesisCare USA - Henderson" are "Drug" (64 trials), "Other" (49 trials), "Biological" (45 trials), "Procedure" (32 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (25 trials), "Computed Tomography" (24 trials), "Quality-of-Life Assessment" (23 trials), "Biospecimen Collection" (22 trials) and "Nivolumab" (18 trials). Other intervention names were less common.

The vast majority of trials in "GenesisCare USA - Henderson" are 76 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "GenesisCare USA - Henderson". undefined are not yet recruiting, 30 are recruiting, 43 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in GenesisCare USA - Henderson, 3 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in GenesisCare USA - Henderson, 2 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".